{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:18:14Z","timestamp":1786997894666,"version":"build-2736575974"},"reference-count":19,"publisher":"Elsevier BV","issue":"34","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T00:00:00Z","timestamp":1562630400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.vaccine.2019.02.061","type":"journal-article","created":{"date-parts":[[2019,7,26]],"date-time":"2019-07-26T16:45:36Z","timestamp":1564159536000},"page":"4775-4777","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Implications and measurement of herd protection (indirect effects) for enteric vaccine development"],"prefix":"10.1016","volume":"37","author":[{"given":"Thomas F.","family":"Wierzba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.02.061_b0005","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1016\/j.vaccine.2016.02.076","article-title":"Status of vaccine research and development for enterotoxigenic Escherichia coli","volume":"34","author":"Bourgeois","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.02.061_b0010","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1016\/j.vaccine.2016.02.075","article-title":"Status of vaccine research and development for Shigella","volume":"34","author":"Mani","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.02.061_b0015","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1098\/rstb.2011.0033","article-title":"Evaluation of vaccines against enteric infections: a clinical and public health research agenda for developing countries","volume":"366","author":"Clemens","year":"2011","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.vaccine.2019.02.061_b0020","series-title":"Design and analysis of vaccine studies","author":"Halloran","year":"2010"},{"key":"10.1016\/j.vaccine.2019.02.061_b0025","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/oxfordjournals.aje.a114291","article-title":"Breast feeding as a determinant of severity in shigellosis. Evidence for protection throughout the first three years of life in Bangladeshi children","volume":"123","author":"Clemens","year":"1986","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2019.02.061_b0030","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0140-6736(05)66550-6","article-title":"Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis","volume":"366","author":"Ali","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2019.02.061_b0035","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1093\/cid\/cit009","article-title":"Herd protection by a bivalent killed whole-cell oral cholera vaccine in the slums of Kolkata, India","volume":"56","author":"Ali","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2019.02.061_b0040","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S1473-3099(12)70196-2","article-title":"Effectiveness of an oral cholera vaccine in Zanzibar: findings from a mass vaccination campaign and observational cohort study","volume":"12","author":"Khatib","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2019.02.061_b0045","doi-asserted-by":"crossref","first-page":"e0003832","DOI":"10.1371\/journal.pntd.0003832","article-title":"Updated global burden of cholera in endemic countries","volume":"9","author":"Ali","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2019.02.061_b0050","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1056\/NEJMoa0904797","article-title":"Effect of human rotavirus vaccine on severe diarrhea in African infants","volume":"362","author":"Madhi","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2019.02.061_b0055","doi-asserted-by":"crossref","first-page":"7142","DOI":"10.1016\/j.vaccine.2018.04.030","article-title":"Direct and possible indirect effects of vaccination on rotavirus hospitalisations among children in Malawi four years after programmatic introduction","volume":"36","author":"Bennett","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.02.061_b0060","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1016\/j.jpeds.2013.03.032","article-title":"Impact and cost-effectiveness of Haemophilus influenzae type b conjugate vaccination in India","volume":"163","author":"Clark","year":"2013","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2019.02.061_b0065","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1097\/01.inf.0000160918.72953.51","article-title":"Pertussis immunization of adolescents in the United States: an economic evaluation","volume":"24","author":"Caro","year":"2005","journal-title":"Pediatr Infect Dis J"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2019.02.061_b0070","doi-asserted-by":"crossref","first-page":"A7","DOI":"10.1016\/j.vaccine.2011.12.096","article-title":"Projected health and economic impact of rotavirus vaccination in GAVI-eligible countries: 2011\u20132030","volume":"30","author":"Atherly","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.02.061_b0075","doi-asserted-by":"crossref","first-page":"6766","DOI":"10.1016\/j.vaccine.2012.09.025","article-title":"The cost-effectiveness of pentavalent rotavirus vaccination in England and Wales","volume":"30","author":"Atkins","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.02.061_b0080","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1524-4733.2009.00562.x","article-title":"Cost-effectiveness of new-generation oral cholera vaccines: a multisite analysis","volume":"12","author":"Jeuland","year":"2009","journal-title":"Value Health"},{"key":"10.1016\/j.vaccine.2019.02.061_b0085","series-title":"Feasibility, coverage and cost of oral cholera vaccination conducted by icddr, b using the existing national immunization service delivery mechanism in rural setting Keraniganj","author":"Khan","year":"2018"},{"key":"10.1016\/j.vaccine.2019.02.061_b0090","doi-asserted-by":"crossref","first-page":"e0006652","DOI":"10.1371\/journal.pntd.0006652","article-title":"The impact and cost-effectiveness of controlling cholera through the use of oral cholera vaccines in urban Bangladesh: a disease modeling and economic analysis","volume":"12","author":"Khan","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2019.02.061_b0095","doi-asserted-by":"crossref","first-page":"6828","DOI":"10.1016\/j.vaccine.2017.10.024","article-title":"Inclusion of the value of herd immunity in economic evaluations of vaccines. A systematic review of methods used","volume":"35","author":"Nymark","year":"2017","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19302683?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19302683?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:33:08Z","timestamp":1759401188000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19302683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":19,"journal-issue":{"issue":"34","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0264410X19302683"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.02.061","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Implications and measurement of herd protection (indirect effects) for enteric vaccine development","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.02.061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}